Central infusion of angiotensin II produced a significant rise in basal heart rate in captopril-treated spontaneously hypertensive rats (371 vs 323 beats/min, p<0.0002).
Does central infusion of angiotensin II alter hemodynamics and baroreceptor reflex function in captopril-treated spontaneously hypertensive rats?
Central infusion of angiotensin II increases basal heart rate and water intake without affecting mean arterial pressure in spontaneously hypertensive rats, regardless of lifetime captopril treatment.
Tasa de eventos absoluta: 371% vs 323%
valor p: p=<0.0002
We examined whether the increase in baroreceptor reflex function previously reported in lifetime - captopril-treated spontaneously hypertensive rats (SHR) was due to an inhibition of brain angiotensin II mechanisms. Pregnant and lactating SHR were given oral captopril (100 mg/kg/day). After weaning, pups were maintained on captopril (50 mg/kg/day) until the study (19-21 weeks). Control rats received tap water. One week before study captopril-treated and control SHR were given an intracerebroventricular infusion of angiotensin II (7.5 ng/hr, osmotic pump) or vehicle (artificial cerebrospinal fluid). Baroreceptor reflex control of heart rate was assessed by the slope of the relation between the change in mean arterial pressure (mm Hg) versus the change in pulse interval (msec beat-1). Arterial pressure was raised or lowered by intravenous bolus injections of phenylephrine or nitroprusside, respectively. Central infusion of angiotensin II had no significant effect on mean arterial pressure in captopril or control SHR (captopril-angiotensin II 125 +/- 4 vs. captopril-vehicle 121 +/- 2; control-angiotensin II 169 +/- 5 vs. control-vehicle 173 +/- 7 mm Hg), but it produced a significant rise in basal heart rate (captopril-angiotensin II 371 +/- 10 vs. captopril-vehicle 323 +/- 8, p less than 0.0002; control-angiotensin II 338 +/- 7 vs. control-vehicle 312 +/- 8 beats/min, p less than 0.0183) and in daily water intake (captopril-angiotensin II 20.7 +/- 2.2 vs. captopril-vehicle 9.8 +/- 0.7, p less than 0.0426; control-angiotensin II 33.1 +/- 3.8 vs. control-vehicle 9.0 +/- 0.6 ml/100 g body wt, p less than 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)
Cheng et al. (Fri,) conducted a other in Spontaneously hypertensive rats. Intracerebroventricular infusion of angiotensin II vs. Vehicle (artificial cerebrospinal fluid) was evaluated on Basal heart rate (p=<0.0002). Central infusion of angiotensin II produced a significant rise in basal heart rate in captopril-treated spontaneously hypertensive rats (371 vs 323 beats/min, p<0.0002).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: